OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis and biological evaluation of nitric oxide releasing derivatives of dapagliflozin as potential anti-diabetic and anti-thrombotic agents
Zheng Li, Xue Xu, Liming Deng, et al.
Bioorganic & Medicinal Chemistry (2018) Vol. 26, Iss. 14, pp. 3947-3952
Closed Access | Times Cited: 11
Zheng Li, Xue Xu, Liming Deng, et al.
Bioorganic & Medicinal Chemistry (2018) Vol. 26, Iss. 14, pp. 3947-3952
Closed Access | Times Cited: 11
Showing 11 citing articles:
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs
Paolo Gresele, Stefania Momi, Giuseppe Guglielmini
Biochemical Pharmacology (2019) Vol. 166, pp. 300-312
Closed Access | Times Cited: 72
Paolo Gresele, Stefania Momi, Giuseppe Guglielmini
Biochemical Pharmacology (2019) Vol. 166, pp. 300-312
Closed Access | Times Cited: 72
Sodium-Glucose Cotransporter Inhibitors as Antidiabetic Drugs: Current Development and Future Perspectives
Rosanna Maccari, Rosaria Ottanà
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 10848-10881
Open Access | Times Cited: 31
Rosanna Maccari, Rosaria Ottanà
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 10848-10881
Open Access | Times Cited: 31
An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent
Sushanta Bhattacharya, Akash Rathore, Deepa Parwani, et al.
European Journal of Medicinal Chemistry (2020) Vol. 204, pp. 112523-112523
Closed Access | Times Cited: 40
Sushanta Bhattacharya, Akash Rathore, Deepa Parwani, et al.
European Journal of Medicinal Chemistry (2020) Vol. 204, pp. 112523-112523
Closed Access | Times Cited: 40
Integrated computational approach on sodium-glucose co-transporter 2 (SGLT2) Inhibitors for the development of novel antidiabetic agents
Sushanta Bhattacharya, Vivek Asati, Mitali Mishra, et al.
Journal of Molecular Structure (2020) Vol. 1227, pp. 129511-129511
Closed Access | Times Cited: 26
Sushanta Bhattacharya, Vivek Asati, Mitali Mishra, et al.
Journal of Molecular Structure (2020) Vol. 1227, pp. 129511-129511
Closed Access | Times Cited: 26
Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease
Zhongcheng Cao, Qing Song, Guangjun Yu, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 35, pp. 116074-116074
Closed Access | Times Cited: 23
Zhongcheng Cao, Qing Song, Guangjun Yu, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 35, pp. 116074-116074
Closed Access | Times Cited: 23
Ameliorative effect of polydatin on hyperglycemia and renal injury in streptozotocin-induced diabetic rats
Lijuan Wang, Liji Huang, Nan Li, et al.
Cellular and Molecular Biology (2019) Vol. 65, Iss. 7, pp. 55-59
Open Access | Times Cited: 8
Lijuan Wang, Liji Huang, Nan Li, et al.
Cellular and Molecular Biology (2019) Vol. 65, Iss. 7, pp. 55-59
Open Access | Times Cited: 8
Dapagliflozin – structure, synthesis, and new indications
Stefan Balkanski
Pharmacia (2021) Vol. 68, Iss. 3, pp. 591-596
Open Access | Times Cited: 6
Stefan Balkanski
Pharmacia (2021) Vol. 68, Iss. 3, pp. 591-596
Open Access | Times Cited: 6
A novel SGLT2 inhibitor, SU-011, improves glycaemic control in rodents without the risk of hypoglycaemia and weight gain
Fei Huang, Fuwei Dai, Jianhua Bi, et al.
Journal of Pharmacy and Pharmacology (2019) Vol. 71, Iss. 9, pp. 1393-1399
Closed Access | Times Cited: 3
Fei Huang, Fuwei Dai, Jianhua Bi, et al.
Journal of Pharmacy and Pharmacology (2019) Vol. 71, Iss. 9, pp. 1393-1399
Closed Access | Times Cited: 3
Recent Advances in the Development of Type 2 Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Ana Karen Estrada, Timoteo Delgado-Maldonado, Edgar E. Lara‐Ramírez, et al.
Mini-Reviews in Medicinal Chemistry (2021) Vol. 22, Iss. 4, pp. 586-599
Closed Access | Times Cited: 3
Ana Karen Estrada, Timoteo Delgado-Maldonado, Edgar E. Lara‐Ramírez, et al.
Mini-Reviews in Medicinal Chemistry (2021) Vol. 22, Iss. 4, pp. 586-599
Closed Access | Times Cited: 3
Tip 2 Diyabetli Hastalarda Dapagliflozin Tedavisinin Trombosit Fonksiyonları ve İnflamasyon Üzerine Etkisi
Mehmet Ali Eren, Çiğdem CİNDOĞLU, Burcu DİKEÇ GÖKÇE, et al.
Uludağ Üniversitesi Tıp Fakültesi Dergisi (2019) Vol. 45, Iss. 3, pp. 291-294
Open Access | Times Cited: 2
Mehmet Ali Eren, Çiğdem CİNDOĞLU, Burcu DİKEÇ GÖKÇE, et al.
Uludağ Üniversitesi Tıp Fakültesi Dergisi (2019) Vol. 45, Iss. 3, pp. 291-294
Open Access | Times Cited: 2
An Updated Review on the Chemistry, Biological Characteristics and Analytical Techniques of Dapagliflozin
Ujwal Chaudhari, Jagdish K. Sahu, Payal Dande
Current Organocatalysis (2023) Vol. 10, Iss. 4, pp. 283-296
Closed Access
Ujwal Chaudhari, Jagdish K. Sahu, Payal Dande
Current Organocatalysis (2023) Vol. 10, Iss. 4, pp. 283-296
Closed Access
